# CHABELINA FE
> **ANDA202962** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2020-04-15
## Drug
- **FDA Application Number:** ANDA202962
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHABELINA FE
- **Generic name:** NDAC AND EE TABLETS AND FERROUS FUMARATE TABLETS
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **Manufacturer:** Mayne Pharma Inc.
- **First approval:** 2020-04-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202962)
---
*AI Analytics · CC0 1.0*